UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Quantiferon Monitor Testing Sheds Light on Immune System Disparities between Multiple Sclerosis Patients and Healthy Individuals

International journal of molecular sciences, 2024-02, Vol.25 (4), p.2179

2024

Volltextzugriff (PDF)

The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis

Drugs in R&D, 2023-12, Vol.23 (4), p.331-338

2023

Volltextzugriff (PDF)

Autoimmune and limbic encephalitis: case series with some atypical variables in clinical practice

Neurological sciences, 2022, Vol.43 (1), p.687-690

2022

Volltextzugriff (PDF)

The role of the immune system and the biomarker CD3 + CD4 + CD45RA−CD62L− in the pathophysiology of migraine

Scientific reports, 2020-07, Vol.10 (1), p.12277, Article 12277

2020

Volltextzugriff (PDF)

Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review

Neuropsychiatric disease and treatment, 2018-01, Vol.14, p.1211-1220

2018

Volltextzugriff (PDF)

Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy

BMC neurology, 2020-05, Vol.20 (1), p.202-202, Article 202

2020

Volltextzugriff (PDF)

DORADA adherence study: full view into RebiSmart subdomains parameters in multiple sclerosis treatment

Current medical research and opinion, 2021-04, Vol.37 (4), p.589-596

2021

Volltextzugriff (PDF)

Response relating to the article 'Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes'

Neurologia i neurochirurgia polska, 2022-01, Vol.56 (3), p.293-293

2022

Volltextzugriff (PDF)

An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart

Expert opinion on drug delivery, 2020-05, Vol.17 (5), p.719-724

2020

Volltextzugriff (PDF)

The direct costs of multiple sclerosis—study in the Czech Republic

Neurological sciences, 2018-12, Vol.39 (12), p.2115-2121

2018

Volltextzugriff (PDF)

Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial

Neuropsychiatric disease and treatment, 2018-01, Vol.14, p.1221-1228

2018

Volltextzugriff (PDF)

Encephalitis with anti-NMDA receptor antibodies: paraneoplastic or non-paraneoplastic?

Neuro-endocrinology letters, 2018-01, Vol.39 (5), p.351-354

2018

Volltextzugriff (PDF)

Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry

Frontiers in neurology, 2022-04, Vol.13, p.851426-851426

2022

Volltextzugriff (PDF)

Tolerability, treatment satisfaction and quality of life outcomes in stable multiple sclerosis patients switched from injectable therapies to auto injected intramuscular interferon beta 1a: The SFERA study

Multiple sclerosis and related disorders, 2019-05, Vol.30, p.104-109

2019

Volltextzugriff (PDF)

CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate

Cells (Basel, Switzerland), 2019-05, Vol.8 (5), p.456

2019

Volltextzugriff (PDF)

Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase

Journal of clinical medicine, 2020-05, Vol.9 (5), p.1468

2020

Volltextzugriff (PDF)

Diagnosis of multiple sclerosis: can errors and mistakes occur?

Neurologie pro praxi, 2023-09, Vol.24 (4), p.274-280

2023

Volltextzugriff (PDF)

Long‑term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data

Neurologie pro praxi, 2023-06, Vol.24 (3), p.206-211

2023

Volltextzugriff (PDF)

Lymphocytes in the treatment with interferon beta-1 b

Multiple sclerosis and related disorders, 2017-11, Vol.18, p.29-32

2017

Volltextzugriff (PDF)

Lymphocyte populations and their change during five-year glatiramer acetate treatment

Neurologia i neurochirurgia polska, 2018-09, Vol.52 (5), p.587-592

2018

Volltextzugriff (PDF)

Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome

Biomedical reports, 2016-07, Vol.5 (1), p.35-40

2016

Volltextzugriff (PDF)

In Silico Studies of Potential Selective Inhibitors of Thymidylate Kinase from Variola virus

Pharmaceuticals (Basel, Switzerland), 2021-10, Vol.14 (10), p.1027

2021

Volltextzugriff (PDF)

Bolesti z nadužívání analgetik - detoxikace?

Neurologie pro praxi, 2020-11, Vol.21 (5), p.406-409

2020

Volltextzugriff (PDF)

Corrigendum to “The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer’s disease” [Biomed. Pharmacother. 159 (2023) 114223]

Biomedicine & pharmacotherapy, 2023-09, Vol.165, p.115226-115226, Article 115226

2023

Volltextzugriff (PDF)

Ocrelizumab, clinical aktivity and progression - long-term data

Neurologie pro praxi, 2019-06, Vol.20 (3), p.204-207

2019

Volltextzugriff (PDF)

1 – 25 von 52

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(48)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(52)

Sprache

Englisch
(52)
Croatian
(1)

Erscheinungsjahr

n.n

Thema

Science & Technology
(30)
Life Sciences & Biomedicine
(29)
Multiple Sclerosis
(20)
Humans
(16)
Neurosciences & Neurology
(15)
Clinical Neurology
(13)
Female
(9)
Multiple Sclerosis - Drug Therapy
(9)
Adult
(8)
Lymphocytes
(8)
Male
(8)
Patients
(8)
Neurology
(7)
Neurosciences
(6)
Treatment
(6)
Biomarkers
(5)
Middle Aged
(5)
Multiple Sclerosis, Relapsing-Remitting - Drug Therapy
(5)
Pharmacology & Pharmacy
(5)
Statistical Analysis
(5)

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Quantiferon Monitor Testing Sheds Light on Immune System Disparities between Multiple Sclerosis Patients and Healthy Individuals

The Benefits and Risks of Switching from Fingolimod to Siponimod for the Treatment of Relapsing–Remitting and Secondary Progressive Multiple Sclerosis

Autoimmune and limbic encephalitis: case series with some atypical variables in clinical practice

The role of the immune system and the biomarker CD3 + CD4 + CD45RA−CD62L− in the pathophysiology of migraine

Treatment of behavioral and psychological symptoms of dementias with psychopharmaceuticals: a review

Highly active RRMS and ocrelizumab after failure of alemtuzumab therapy

DORADA adherence study: full view into RebiSmart subdomains parameters in multiple sclerosis treatment

Response relating to the article 'Primary progressive multiple sclerosis overlapping with anti-GAD and anti-Hu antibodies positive neurological syndromes'

An observational study demonstrating the adherence and ease of use of the injector device, RebiSmart

The direct costs of multiple sclerosis—study in the Czech Republic

Acupuncture in migraine prophylaxis in Czech patients: an open-label randomized controlled trial

Encephalitis with anti-NMDA receptor antibodies: paraneoplastic or non-paraneoplastic?

Analysis of the Group of Pediatric Patients With Relapsing-Remitting Multiple Sclerosis: Data From the Czech National Registry

Tolerability, treatment satisfaction and quality of life outcomes in stable multiple sclerosis patients switched from injectable therapies to auto injected intramuscular interferon beta 1a: The SFERA study

CD4+/CD45RO+: A Potential Biomarker of the Clinical Response to Glatiramer Acetate

Innate Immune System and Multiple Sclerosis. Granulocyte Numbers Are Reduced in Patients Affected by Relapsing-Remitting Multiple Sclerosis during the Remission Phase

Diagnosis of multiple sclerosis: can errors and mistakes occur?

Long‑term efficacy and safety of siponimod in patients with secondary progressive multiple sclerosis: Analysis of EXPAND core and extension data

Lymphocytes in the treatment with interferon beta-1 b

Lymphocyte populations and their change during five-year glatiramer acetate treatment

Proteomic analysis of cerebrospinal fluid for relapsing-remitting multiple sclerosis and clinically isolated syndrome

In Silico Studies of Potential Selective Inhibitors of Thymidylate Kinase from Variola virus

Bolesti z nadužívání analgetik - detoxikace?

Corrigendum to “The measured CSF/plasma donepezil concentration ratio but not individually measured CSF and plasma concentrations significantly increase over 24 h after donepezil treatment in patients with Alzheimer’s disease” [Biomed. Pharmacother. 159 (2023) 114223]

Ocrelizumab, clinical aktivity and progression - long-term data

Suchergebnisse filtern